Artwork

Content provided by BMJ talk medicine and BMJ Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BMJ talk medicine and BMJ Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Statins for primary prevention - How good is the evidence

21:28
 
Share
 

Manage episode 244768693 series 1426077
Content provided by BMJ talk medicine and BMJ Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BMJ talk medicine and BMJ Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Statins are now the most commonly used drug in the UK and one of the most commonly used medicines in the world, but debate remains about their use for primary prevention for people without cardiovascular disease. Paula Byrne from the National University of Ireland Galway, joins us to talk about the evidence of benefit for low risk individuals, and what needs to be done to finally answer the questions about efficacy and harms. Read the full analysis: https://www.bmj.com/content/367/bmj.l5674
  continue reading

425 episodes

Artwork
iconShare
 
Manage episode 244768693 series 1426077
Content provided by BMJ talk medicine and BMJ Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BMJ talk medicine and BMJ Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Statins are now the most commonly used drug in the UK and one of the most commonly used medicines in the world, but debate remains about their use for primary prevention for people without cardiovascular disease. Paula Byrne from the National University of Ireland Galway, joins us to talk about the evidence of benefit for low risk individuals, and what needs to be done to finally answer the questions about efficacy and harms. Read the full analysis: https://www.bmj.com/content/367/bmj.l5674
  continue reading

425 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide